[O2-4] SARS2-4

[O2-4-10] Development of live-attenuated SARS-CoV-2 vaccine platform based on temperature sensitive strains

*Akiho Yoshida^1,2, Shinya Okamura^1,2, Sayuri Komatsu^1,2, Shiro Takekawa², Koichi Yamanishi², Hirotaka Ebina^1,2 (1. Virus Vaccine group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, 2. The Research Foundation for Microbial Diseases of Osaka University)